IP Library Granted Patent US 10,420,503
Granted Patent B2
US 10,420,503 · App. 15/282,364 · Granted Sep 24, 2019

Method of measuring efficacy of treatment for multiple sclerosis

Inventors: Daniel J. Ford (San Francisco, CA); Laura Schaevitz (Los Gatos, CA)
Assignee: Vium, Inc.
A61B5/4848A01K1/031A01K29/005A61B5/1118A61B5/4076A61B5/4842A61B5/7282A61B5/7257A61B2503/40A61B2503/42A61D99/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,420,503
App. No.
15/282,364
Granted
Sep 24, 2019
Kind
B2
Abstract

A method of measuring efficacy of treatment of multiple sclerosis (MS) in an animal in a vivarium is described. Animal activity data is collected at multiple times during the night. Sequential time regions of the night are identified as high-activity, activity-drop, or low-activity regions. Embodiments are described to quantify a drop, during the night, of an animal's activity level. These quantified activity-drop scalars for consecutive nights are accumulated in an animal health dataset. This dataset is compared to healthy animals or a standard of care to determine efficacy. One embodiment quantifies an activity-drop by fitting straight-line curves through the data in the three nightly regions. Another embodiment uses a Fourier transform on a circle and a linear combination. Another embodiment compares areas under data curves in the regions. Animals may be housed in cages with other animals.

Claims (20)

1. A method of measuring efficacy of a first treatment of multiple sclerosis (MS) in an animal in a vivarium comprising the steps of:

(a) placing a study animal in a cage in the vivarium and enrolling the study animal in a study;

(b) electronically observing one or more animal activities in real-time of the study animal using a combination of electronic cameras, infrared (IR) lighting of the study animals, and electronic hardware including computation and communication hardware;

(c) selecting a single “LASSO metric” with an associated scalar “activity-drop value”;

(d) selecting an “MS health detection function,” wherein an input to the MS health detection function comprises an animal health dataset; and wherein an output of the MS health detection function comprises an animal health severity scalar for the animal;

(e) collecting a set of nightly activity data for the animal comprising a plurality of activity scalars for the animal each night, wherein the nightly activity scalars are collected repeatedly and continually throughout a night;

(f) computing a LASSO best-fit of a first piece-wise linear function to the nightly activity data, generating a LASSO L0, L1 and L2;

(g) applying the LASSO metric to the generated LASSO L0, L1 and L2, generating a nightly activity-drop value;

(h) adding the nightly activity-drop value into the “animal health dataset,” wherein the animal health dataset comprises the nightly activity-drop values;

(i) applying the MS health detection function to the animal health dataset;

(j) iterating steps (f) through (h) for sequential nights until a terminating condition is reached;

wherein a first measured efficacy of the first treatment comprises

comparing the animal health severity scalars from step (i) to animal health severity scalars from a reference treatment;

(k) removing the study animal from the study when the terminating condition is reached.

2. The method of claim 1 wherein:

the first piece-wise linear function comprises two linear pieces; and

wherein the nightly activity-drop value comprises a linear combination of LASSO L0, L1 and L2.

3. The method of claim 1 wherein:

the first piece-wise linear function comprises three linear pieces; and

wherein the nightly activity-drop value comprises a linear combination of LASSO L0, L1 and L2.

Assignments (7)
CORRECTIVE ASSIGNMENT TO CORRECT THE RECEIVING PARTIES NAME FROM RECURSION PHARMACEUTICALS, INC. TO VIUM (ABC) LLC AND PROPERTY NUMBERS FROM 34 TO 42 TOTAL ATTACHMENTS FROM 19 PAGES TO 9 PAGES PREVIOUSLY RECORDED ON REEL 54439 FRAME 362. ASSIGNOR(S) HEREBY CONFIRMS THE NUNC PRO TUNC ASSIGNMENT . Recorded Mar 25, 2024
From: VIUM, INC.
To: VIUM (ABC) LLC
Reel/Frame 066893/0379 →
CORRECTIVE ASSIGNMENT TO CORRECT THE THE APPLICATION NUMBER PREVIOUSLY RECORDED AT REEL: 053047 FRAME: 0191. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Aug 4, 2021
From: VIUM, INC.
To: SILICON VALLEY BANK
Reel/Frame 057085/0787 →
CORRECTIVE ASSIGNMENT TO CORRECT THE D877354 PREVIOUSLY RECORDED AT REEL: 055620 FRAME: 0040. ASSIGNOR(S) HEREBY CONFIRMS THE RELEASE OF SERCURITY INTEREST. Recorded Aug 4, 2021
From: SILICON VALLEY BANK
To: RECURSION PHARMACEUTICALS, INC.
Reel/Frame 057086/0684 →
RELEASE OF SECURITY INTEREST Recorded Mar 16, 2021
From: SILICON VALLEY BANK
To: RECURSION PHARMACEUTICALS, INC.
Reel/Frame 055620/0040 →
NUNC PRO TUNC ASSIGNMENT Recorded Nov 22, 2020
From: VIUM, INC.
To: RECURSION PHARMACEUTICALS, INC.
Reel/Frame 054439/0362 →
NUNC PRO TUNC ASSIGNMENT Recorded Nov 22, 2020
From: VIUM, INC.
To: RECURSION PHARMACEUTICALS, INC.
Reel/Frame 054439/0387 →
SECURITY INTEREST Recorded Jun 25, 2020
From: VIUM, INC.
To: SILICON VALLEY BANK
Reel/Frame 053047/0192 →
Continuity (1)
Related Publication 20180092596A1 · Apr 5, 2018